Skip to content

Cellectar Biosciences, Inc.

CLRB Nasdaq SEC CIK 1279704

Follow Cellectar Biosciences Weekly email: filings, results, news

News

2 stories filed under Cellectar Biosciences

Cellectar Biosciences, Inc. (CLRB) Discusses Scientific Rationale and Potential of Phospholipid Ether Platform in Targeted Cancer Therapy - Slideshow

Markets 37 d ago

Cellectar Biosciences, Inc. (CLRB) Q2 2026 Earnings Call Transcript

Earnings 42 d ago

Profile

Headquarters: FLORHAM PARK, NJ, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 2 stories clustered from the RSS aggregator